Updated on 20 August 2026
Clinical trial support and Research Collaboration
researcher at Jagiellonian University Medical College
Krakow, Poland
About
Organizational and scientific support for the implementation of clinical trials, including coordination of research activitis, analysis and interpretation of study results, continuous monitoring of research progress, and preparation of final reports. Collaboration may include support throughout the entire research process, from project implementation to study completion and reporting.
Topic
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Similar opportunities
Project cooperation
Clinical Data Management and Biobanking Services
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Natalia Wilczyńska-Zawal
researcher at Jagiellonian University Medical College
Krakow, Poland
Project cooperation
(CANCER-03) GMP manufacturing and first-in-human trial delivery for rare-cancer therapeutics
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Ilias Nikolinakos
EU Grants and Funding Coordinator at Elpen Pharmaceutical Co. Inc.
Athens, Greece
Project cooperation
Organ on chips, organoids and other NAMs for biomedical research
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Joude Cachoux
Business Development Manager, PharmD, MPH at Leitat Technological Center
Barcelona, Spain